Ribonucleotide reductase subunit one as gene therapy target

Clinical Cancer Research

Volumn 9, Issue 12, 2003, Pages 4304-4308

  Yen, Yun ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBONUCLEOTIDE REDUCTASE;

ADENOVIRUS; CANCER INHIBITION; CANCER INVASION; CHROMOSOME 11P; COLON ADENOCARCINOMA; DNA REPAIR; GENE DUPLICATION; GENE EXPRESSION; GENE INACTIVATION; GENE MAPPING; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; GENE THERAPY; HETEROZYGOSITY LOSS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; COLONIC NEOPLASMS; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; RIBONUCLEOTIDE REDUCTASES;

EID: 0141960455     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Thelander, L., and Reichard, P. Reduction of ribonucleotides. Annu. Rev. Biochem., 48: 133-158, 1979.
2. Reichard, P. Ribonucleotide reductases: the evolution of allosteric regulation. Arch. Biochem. Biophys., 397: 149-155, 2002.
3. Nocentini, G. Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy. Crit. Rev. Oncol. Hematol., 22: 89-126, 1996.
4. Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., and Nakamura, Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature (Lond.), 404: 42-49, 2000.
5. Nakano, K., Balint, E., Ashcroft, M., and Vousden, K. H. A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene, 19: 4283-4289, 2000.
6. Yamaguchi, T., Matsuda, K., Sagiya, Y., Iwadate, M., Fujino, M. A., Nakamura, Y., and Arakawa, H. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint. Cancer Res., 61: 8256-8262, 2001.
7. Hurta, R. A., and Wright, J. A. Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent. J. Biol. Chem., 267: 7066-7071, 1992.
8. Guittet, O., Hakansson, P., Voevodskaya, N., Fridd, S., Graslund, A., Arakawa, H., Nakamura, Y., and Thelander. L. Mammalian p53R2 protein forms an active ribonucleotide reductase in vitro with the R1 protein, which is expressed both in resting cells in response to DNA damage and in proliferating cells. J. Biol. Chem., 276: 40647-40651, 2001.
9. Angus, S. P., Wheeler, L. J. Ranmal, S. A., Zhang, X., Markey, M. P., Mathews, C. K., and Knudsen, E. S. The retinoblastoma tumor suppressor targets dNTP metabolism to regulate DNA replication, J. Biol. Chem., 277: 44376-44384, 2002.
10. Yen, Y., Grill, S., Dutshman, G., and Chen, Y-C. Characterization of hydroxyurea resistant human KB cell line with collateral sensitivity to 6-thioguanine. Cancer Res., 54: 3686-3691, 1994.
11. Fan, H., Villegas, C., Huang, A., and Wright. J. A. The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation. Cancer Res., 58: 1650-1653, 1998.
12. Fan, H., Huang, A., Villegas, C., and Wright, J. A. The RI component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments. Proc. Natl. Acad. Sci. USA, 94: 13181-13186, 1997.
13. Zhou, B. S., Hsu, N. Y., Pan, B. C., Doroshow, J. H., and Yen, Y. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells. Cancer Res., 55: 1328-1333, 1995.
14. Huang, A., Fan, H., Taylor, W. R., and Wright, J. A. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability. Cancer Res., 57: 4876-4881, 1997.
15. Goan, Y. G., Zhou, B., Hu, E., Mi, S., and Yen, Y. Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2-defluorodeoxycyctidine in the human KB cancer cell line. Cancer Res., 59: 4204-4207, 1999.
16. Zhou, B. S., Tsai, P., Ker, R., Tsai, J., Ho, R., Yu, J., Shih, J., and Yen, Y. Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential. Clin. Exp. Metastasis, 16: 43-49, 1998.
17. Chen, S-Y., Zhou, B-S., He, F., and Yen, Y. The inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA. Antisense Nucleic Acid Drug Dev., 10: 111-116, 2000.
18. Kuschak, T. I., Kuschak, B. C., Taylor, C. L., Wright, J. A., Wiener, F., and Mai, S. c-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene. Oncogene, 21: 909-920, 2002.
19. Kuschak, T. I., Taylor, C., McMillan-Ward, E., Israels, S., Henderson, D. W., Mushinski, J. F., Wright, J. A., and Mai, S. The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability. Gene (Amst.), 238: 351-365, 1999.
20. Yang-Feng, T. L., Barton, D. E., Thelander, L., Lewis, W. H., Srinivasan, P. R., and Francke, U. Ribonucleotide reductase M2 subunit sequences mapped to four different chromosomal sites in humans and mice: functional locus identified by its amplification in hydroxyurea-resistant cell lines. Genomics, 1: 77-86, 1987.
21. Bepler, G., Gautam, A., McIntyre, L. M., Beck, A. F., Chervinsky, D. S., Kim, Y. C., Pitterle, D. M., and Hyland, A. Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer. J. Clin. Oncol., 20: 1353-1360, 2002.
22. Bepler, G., and Garcia-Blanco, M. A. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer. Proc. Natl. Acad. Sci. USA, 91: 5513-5517, 1994.
23. Tran, Y. K., and Newsham, I. F. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared with breast carcinomas. Cancer Res., 56: 2916-2921, 1996.
24. Ali, I. U., Lidereau, R., Theillet, C., and Callahan, R. Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia. Science (Wash. DC), 238: 185-188, 1987.
25. Viel, A., Giannini, F., Tumiotto, L., Sopracordevole, F., Visentin, M. C., and Boiocchi, M. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours. Br. J. Cancer, 66: 1030-1036, 1992.
26. Ranzani, G. N., Renault, B., Pellegata, N. S., Fattorini, P., Magni, E., Bacci, F., and Amadori, D. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum. Genet., 92: 244-249, 1993.
27. Karnik, P., Paris, M., Williams, B. R., Casey, G. Crowe, J., and Chen, P. Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis. Hum. Mol. Genet., 7: 895-903, 1998.
28. Bepler, G., Fong, K. M., Johnson, B. E., O'Briant, K. C., Daly, L. A., Zimmerman, P. V., Garcia-Blanco, M. A., and Peterson, B. Association of chromosome 11 locus D11S12 with histology, stage, and metastases in lung cancer. Cancer Detect. Prev., 22: 14-19, 1998.
29. Pitterle, D. M., Kim, Y. C., Jolicoeur, E. M., Cao, Y., O'Briant, K. C., and Bepler, G. Lung cancer and the human gene for ribonucleotide reductase subunit M1 (RRMI). Mamm. Genome, 10: 916-922, 1999.
30. O'Briant, K. C., and Bepler, G. Delineation of the centromeric and telomeric chromosome segment 11p15.5 lung cancer suppressor regions LOH11A and LOH11B. Genes Chromosomes Cancer, 18: 111-114. 1997.
31. Srivatsan, E. S., Benedict, W. F., and Stanbridge, E. J. Implication of chromosome 11 in the suppression of neoplastic expression in human cell hybrids. Cancer Res., 46: 6174-6179, 1986.
32. Koi, M., Johnson, L. A., Kalikin, L. M., Little, P. F., Nakamura, Y., and Feinberg, A. P. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science (Wash. DC), 260: 361-364, 1993.
33. Phillips, K. K., Welch, D. R., Miele, M. E., Lee, J. H., Wei, L. L., and Weissman, B. E. Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res., 56: 1222-1227, 1996.
34. Reid, L. H., West, A., Gioeli, D. G., Phillips, K. K., Kelleher, K. F., Araujo, D., Stanbridge, E. J., Dowdy, S. F., Gerhard, D. S., and Weissman, B. E. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay. Hum. Mol. Genet., 5: 239-247, 1996.
35. O'Briant, K., Jolicoeur, E., Garst, J., Campa, M., Schreiber, G., and Bepler, G. Growth inhibition of a human lung adenocarcinoma cell line by genetic complementation with chromosome 11. Anticancer Res., 17: 3243-3251, 1997.
36. Cao, M-Y., Lee, Y., Feng, N-P., Xiong, K., Hongnan, J., Wang, M., Vassilakos, A., Viau, S., Wright, J. A., and Young, A. H. Adenovirus-mediated ribonucleotide reductase RI gene therapy of human colon adenocarcinoma. Clin, Cancer Res., 9: 4304-4308, 2003.
37. Grady, M. Genetic and epigenetic alterations in colon cancer. Annu. Rev. Genomics Hum. Genet., 3: 101-128, 2002.
38. Spitz, F. R., Nguyen, D., Skibber, J. M., Cusack, J., Roth, J. A., and Cristiano, R. J. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer. Anticancer Res., 16: 3415-3422, 1996.
39. Ko, S. C., Gotoh, A., Thalmann, G. N., Zhau, H. E., Johnston, D. A., Zhang, W. W., Kao, C., and Chung, L. W. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model. Hum. Gene. Ther., 7: 1683-1691, 1996.
40. Nielsen, L. L., Dell, J., Maxwell, E., Armstrong, L., Maneval, D., and Catino, J. J. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Cancer Gene Ther., 4: 129-138, 1997.
41. Hamada, K., Zhang, W. W., Alemany, R., Wolf, J., Roth, J. A., and Mitchell, M. F. Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro. Gynecol. Oncol., 60: 373-379, 1996.
42. Mujoo, K., Maneval, D. C., Anderson, S. C., and Gutterman, J. U. Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma. Oncogene, 12: 1617-1623, 1996.
43. Cirielli, C., Riccioni, T., Yang, C., Pili, R., Gloe, T., Chang, J., Inyaku, K., Passaniti, A., and Capogrossi, M. C. Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int. J. Cancer, 63: 673-679, 1995.
44. Fan, H., Villegas, C., and Wright, J. A. Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential. Proc. Natl. Acad. Sci. USA, 93: 14036-14040, 1996.
45. Zhao, B., and Bepler, G. Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer. Oncogene, 20: 8154-8164, 2001.
46. Knudson, A. G., Jr. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68: 820-823, 1971.
47. Fero, M, L., Randel, E., Gurley, K. E., Roberts, J. M., and Kemp, C. J. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature (Lond.), 396: 177-180, 1998.
48. Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L. H., Broudy, V., Perlmutter, R. M., Kaushansky, K., and Roberts, J. M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell, 85: 733-744, 1996.
49. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., and Koff, A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9-22, 1994.
50. Hurta, R. A., Samuel, S. K., Greenberg, A. H., and Wright, J. A. Early induction of ribonucleotide reductase gene expression by transforming growth factor β1 in malignant H-ras transformed cell lines. J. Biol. Chem., 266: 24097-100, 1991.
51. Bjorklund, S., Skog, S., Tribukait, B., and Thelander, L. S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry, 29: 5452-5458, 1990.
52. Engstrom, Y., Eriksson, S., Jildevik, I., Skog, S., Thelander, L., and Tribukait, B. Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits J. Biol. Chem., 260: 9114-9116, 1985.